ID PRVB_MERME Reviewed; 108 AA. AC P02620; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 21-JUL-1986, sequence version 1. DT 27-NOV-2024, entry version 99. DE RecName: Full=Parvalbumin beta; OS Merluccius merluccius (European hake). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Actinopterygii; Neopterygii; Teleostei; Neoteleostei; Acanthomorphata; OC Zeiogadaria; Gadariae; Gadiformes; Gadoidei; Merlucciidae; Merluccius. OX NCBI_TaxID=8063; RN [1] RP PROTEIN SEQUENCE. RX PubMed=4569071; DOI=10.1111/j.1432-1033.1973.tb02584.x; RA Capony J.-P., Ryden L., Demaille J.G., Pechere J.-F.; RT "The primary structure of the major parvalbumin from hake muscle. RT Overlapping peptides obtained with chemical and enzymatic methods. The RT complete amino-acid sequence."; RL Eur. J. Biochem. 32:97-108(1973). RN [2] RP PROTEIN SEQUENCE, MASS SPECTROMETRY, AND ACETYLATION AT ALA-1. RC TISSUE=Muscle; RX PubMed=20586483; DOI=10.1021/pr100163e; RA Carrera M., Canas B., Vazquez J., Gallardo J.M.; RT "Extensive de novo sequencing of new parvalbumin isoforms using a novel RT combination of bottom-up proteomics, accurate molecular mass measurement by RT FTICR-MS, and selected MS/MS ion monitoring."; RL J. Proteome Res. 9:4393-4406(2010). CC -!- FUNCTION: In muscle, parvalbumin is thought to be involved in CC relaxation after contraction. It binds two calcium ions. CC -!- MASS SPECTROMETRY: Mass=11329.746; Mass_error=0.0013; CC Method=Electrospray; Evidence={ECO:0000269|PubMed:20586483}; CC -!- MISCELLANEOUS: This is the major hake parvalbumin. CC -!- MISCELLANEOUS: This parvalbumin has an isoelectric point of 4.36. CC -!- MISCELLANEOUS: Is regarded as an important allergen. CC -!- SIMILARITY: Belongs to the parvalbumin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR PIR; A03055; PVHK. DR AlphaFoldDB; P02620; -. DR SMR; P02620; -. DR Allergome; 7643; Mer mr 1. DR iPTMnet; P02620; -. DR GO; GO:0005737; C:cytoplasm; IEA:TreeGrafter. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR CDD; cd16255; EFh_parvalbumin_beta; 1. DR FunFam; 1.10.238.10:FF:000060; Parvalbumin, thymic; 1. DR Gene3D; 1.10.238.10; EF-hand; 1. DR InterPro; IPR011992; EF-hand-dom_pair. DR InterPro; IPR018247; EF_Hand_1_Ca_BS. DR InterPro; IPR002048; EF_hand_dom. DR InterPro; IPR008080; Parvalbumin. DR PANTHER; PTHR11653:SF12; PARVALBUMIN; 1. DR PANTHER; PTHR11653; PARVALBUMIN ALPHA; 1. DR Pfam; PF13499; EF-hand_7; 1. DR PRINTS; PR01697; PARVALBUMIN. DR SUPFAM; SSF47473; EF-hand; 1. DR PROSITE; PS00018; EF_HAND_1; 2. DR PROSITE; PS50222; EF_HAND_2; 2. PE 1: Evidence at protein level; KW Acetylation; Allergen; Calcium; Direct protein sequencing; Metal-binding; KW Muscle protein; Repeat. FT CHAIN 1..108 FT /note="Parvalbumin beta" FT /id="PRO_0000073614" FT DOMAIN 38..73 FT /note="EF-hand 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 77..108 FT /note="EF-hand 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 51 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 53 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 55 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 57 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P02621" FT BINDING 59 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:P02621" FT BINDING 62 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 90 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 92 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 94 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 96 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 101 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT MOD_RES 1 FT /note="N-acetylalanine" FT /evidence="ECO:0000269|PubMed:20586483, FT ECO:0000269|PubMed:4569071" SQ SEQUENCE 108 AA; 11295 MW; E5526ACBF3DC3B64 CRC64; AFAGILADAD ITAALAACKA EGSFKHGEFF TKIGLKGKSA ADIKKVFGII DQDKSDFVEE DELKLFLQNF SAGARALTDA ETATFLKAGD SDGDGKIGVE EFAAMVKG //